• Flickr
  • LinkedIn
  • Youtube
LOG IN | +33 (0) 5 49 36 11 37
  • Français
  • English
  • 中文
  • Português
  • 0Shopping Cart
QIMA Life Sciences
  • Our solutions
    • in silico testing & chemoinformatics
      • in silico screening
      • Phytochemical analysis & metabolic profiling
    • in vitro and ex vivo testing
      • Catalogue
      • Cell and tissue engineering
      • Histology services
        • Slide preparation
        • Histological staining
        • Immunolabeling
        • Electron microscopy TEM/SEM
        • Slide scanning
      • Gene expression and transcriptomic analysis
        • RNA extraction and quality control
        • Rt-qPCR & PCRarrays
        • Microarrays
        • miRNA
        • In situ hybridization
        • Bioinformatics
      • Skin microbiota analysis
      • Assays on fresh whole blood
    • Preclinical Analysis
      • Analytical chemistry and bioanalysis
    • Bioanalysis & Clinical Imaging
      • Non-invasive clinical samples
      • Bioanalysis of non-invasive clinical samples
      • Clinical Imaging
  • Your Industry
    • Cosmetics
      • Hydration and skin barrier
      • Epidermal regeneration
      • Skin firmness & cohesion
      • Skin ageing
      • Skin protection & defense
      • Skin pigmentation
      • Oily skin and hyperseborrhea
      • Skin microbiota
      • Slimming and adipocyte metabolism
      • Skin microcirculation and vascularization
      • Hair growth, alopecia & canities
    • Dermatology
      • Acne
      • Alopecia, hair growth & canities
      • Wound healing and skin regeneration
      • Atopic dermatitis
      • Psoriasis
      • Skin microbiota
      • Melanoma
      • Vitiligo (coming soon)
    • Pharmacology
      • Immuno-Inflammation
      • Neurobiology
    • Veterinary medicine
  • About QIMA Life Sciences
    • Company Values
    • Who we are
    • Our commitments and responsibilities
    • Our team
    • Resources
      • Documentary resources
      • Publications
      • Webinars
      • Thematic videos
  • Careers
  • Contact
  • Menu Menu

PSORIASIS

Psoriasis is a non-contagious inflammatory skin disease linked to a genetic predisposition and which develops under the influence of environmental parameters. While no treatment can completely cure this autoimmune disease, psoriasis is the subject of intensive research and especially so since the identification of subpopulations of Th17 and Th22 lymphocytes.

Psoriasis: in vitro models and assays

With the assistance of its academic partners (Laboratoire Inflammation, Tissus Epithéliaux et Cytokines, LITEC, EA 4331) and hospital partners (University Hospital Center of Poitiers),  QIMA Life Sciences has carried out an extensive research program on psoriasis for more than a decade. Our work is particularly aimed at better characterizing the role as well as the individual or combined effects of Th1, Th17 and Th22 cytokines (e.g.  IL-17A, IL-22, IL-1alpha, OSM and TNF-alpha) on the development of cutaneous inflammation and inhibition of skin differentiation. Today QIMA Life Sciences offers a full range of innovative models and in vitro pharmacology assays specifically dedicated to the evaluation of pharmacological efficacy (screening, profiling, proof-of-concept) of your products (APIs, biosimilars, formulations, medical devices):

  • Immune response (Th17/Th22 cytokine release)
  • Induction in keratinocytes (or reconstructed epidermis) of a  psoriasis-like profile by cytokines
  • Production of chemokines, antimicrobial peptides (AMPs) and expression of epidermal differentiation markers
  • Specific marker analysis by immunoassays or RT-qPCR

Here are a few examples among all the standard assays proposed by QIMA Life Sciences in the field of psoriasis:

  • DEFB4 gene expression

    NHEK, gene expression (cytokine stimulation)

    1.00€
    Add to cart Show Details
  • Cytokine-induced DEFB4 gene expression

    RHE, gene expression (cytokine stimulation)

    1.00€
    Add to cart Show Details
  • HE staining#Stim

    RHE, histology (cytokine stimulation)

    1.00€
    Add to cart Show Details
  • Beta defensin 2 release

    NHEK, antimicrobial peptide release (cytokine stimulation)

    1.00€
    Add to cart Show Details
  • IL-8 release

    NHEK, chemokine release (cytokine stimulation)

    1.00€
    Add to cart Show Details

Psoriasis: clinical bioanalysis

Analysis of markers of inflammation

Our company has developed ready-to-use non-invasive collection kits to analyze the lipids and biomarkers of the skin surface from your samples or from those of your clinical center.

The markers of inflammation are also analyzed from samples using the SW Kit (cytokines, cascade of fatty acids, PGE2).

These evaluations help support your claims about the efficacy of soothing skincare products, protective products, anti-inflammatory products, etc.

Screening des marqueurs de l'inflammation

Screening of inflammation markers

Find out about all our standard assays - Direct access to catalog
A project, an idea or a question? Contact us and let’s talk about it!

Psoriasis: posts and publications

Interleukin-17A-induced production of acute serum amyloid A by keratinocytes contributes to psoriasis pathogenesis

Psoriasis

Acute-serum Amyloid A (A-SAA), one of the major acute-phase proteins, is mainly produced in the liver but extra-hepatic synthesis involving the skin has been reported. Its expression is regulated by the transcription factors NF-κB, C/EBPβ, STAT3 activated by proinflammatory cytokines.

Read more
https://qima-lifesciences.com/wp-content/uploads/2017/08/IL-17A.png 368 655 Guillaume https://qima-lifesciences.com/wp-content/uploads/2021/10/QIMA_life_sciences@4x1.png Guillaume2017-07-14 09:37:162019-08-01 15:20:02Interleukin-17A-induced production of acute serum amyloid A by keratinocytes contributes to psoriasis pathogenesis
imiquimod

Imiquimod-induced skin inflammation in mice is dependent on IL-1R1 and MyD88 signaling but independent of the NLRP3 inflammasome

Psoriasis

The pathogenesis of inflammatory skin diseases such as psoriasis involves the release of numerous proinflammatory cytokines, including members of the IL-1 family. Here we report overexpression of IL-1α, IL-1β, and IL-1 receptor antagonist mRNA, associated to expression of IL-23p19, IL-17A, and IL-22 in skin cells

Read more
https://qima-lifesciences.com/wp-content/uploads/2016/03/mw_imq-induced-skin-inflammation.jpg 368 655 Guillaume https://qima-lifesciences.com/wp-content/uploads/2021/10/QIMA_life_sciences@4x1.png Guillaume2015-07-24 17:30:202018-10-24 21:56:11Imiquimod-induced skin inflammation in mice is dependent on IL-1R1 and MyD88 signaling but independent of the NLRP3 inflammasome

Inhibition of keratinocyte differentiation by the synergistic effect of IL-17A, IL-22, IL-1α, TNFα and oncostatin M

Inflammation, Psoriasis

This study highlights the precise role of cytokines in the skin inflammatory response (psoriasis). IL-22 and OSM more specifically drive epidermal hyperplasia and differentiation loss while IL-1α, IL-17A and TNFα were more involved in the activation of innate immunity.

Read more
https://qima-lifesciences.com/wp-content/uploads/2016/03/mw_inhibition-of-keratinocyte-differentiation.jpg 368 655 Guillaume https://qima-lifesciences.com/wp-content/uploads/2021/10/QIMA_life_sciences@4x1.png Guillaume2014-07-10 16:22:302018-10-24 22:00:08Inhibition of keratinocyte differentiation by the synergistic effect of IL-17A, IL-22, IL-1α, TNFα and oncostatin M

Contribution of IL22 to experimental skin inflammation

Inflammation, Psoriasis

Focused on in vitro human models, we present the mechanisms of action of IL22 as well as its involvement in structure, metabolism, differentiation, chemotaxis, antibacterial activity, innate immunity, and tissue remodeling of epidermis.

Read more
https://qima-lifesciences.com/wp-content/uploads/2013/04/mw_Contribution-of-IL-22.jpg 368 655 Guillaume https://qima-lifesciences.com/wp-content/uploads/2021/10/QIMA_life_sciences@4x1.png Guillaume2013-04-11 15:14:312018-10-24 22:00:41Contribution of IL22 to experimental skin inflammation

Keratinocytes under fire of proinflammatory cytokines: Bonafide innate immune cells involved in the physiopathology of chronic atopic dermatitis and psoriasis

Atopic dermatitis, Dermatite atopique, Psoriasis

Specific cytokine environment deregulation plays a central role on skin morphology and innate immunity, moving towards specific pathologies and opening the way to new therapeutic strategies.

Read more
https://qima-lifesciences.com/wp-content/uploads/2016/05/mw_keratinocytes-under-fire.jpg 368 655 Guillaume https://qima-lifesciences.com/wp-content/uploads/2021/10/QIMA_life_sciences@4x1.png Guillaume2012-10-05 16:11:462019-11-12 17:47:46Keratinocytes under fire of proinflammatory cytokines: Bonafide innate immune cells involved in the physiopathology of chronic atopic dermatitis and psoriasis

Skin inflammation induced by the synergistic action of IL17A, IL22, OSM, IL1α and TNFα recapitulates some features of psoriasis

Psoriasis

Our results demonstrate the important potentiating activities of IL17A, IL22, oncostatin M, TNF-alpha, and IL1alpha on keratinocytes. This is particularly interesting in the context of psoriasis where these cytokines are overexpressed and could synergize to play an important role in upregulation of chemokines and antimicrobial peptides production.

Read more
https://qima-lifesciences.com/wp-content/uploads/2016/05/mw_Skin-inflammation-induced-by-the-synergistic-action-of-IL-17A.jpg 368 655 Guillaume https://qima-lifesciences.com/wp-content/uploads/2021/10/QIMA_life_sciences@4x1.png Guillaume2010-03-26 15:25:302018-10-24 22:04:30Skin inflammation induced by the synergistic action of IL17A, IL22, OSM, IL1α and TNFα recapitulates some features of psoriasis
skin inflammation

Keratinocytes as targets for cytokines in skin inflammation

Acne, Atopic dermatitis, Dermatology, Psoriasis

Current knowledge about the effects of different cytokine families on keratinocytes, and more particularly theirinvolvement in skin inflammation and in the development of inflammatory skin diseases such as psoriasis

Read more
https://qima-lifesciences.com/wp-content/uploads/2016/05/mw_Keratinocytes-as-targets-for-cytokines.jpg 368 655 Guillaume https://qima-lifesciences.com/wp-content/uploads/2021/10/QIMA_life_sciences@4x1.png Guillaume2008-11-20 14:50:532019-05-31 09:36:35Keratinocytes as targets for cytokines in skin inflammation
CEACAM1

Cytokine-induced CEACAM1 expression on keratinocytes is characteristic for psoriatic skin and contributes to a prolonged lifespan of neutrophils

Psoriasis

These results show that cytokine-induced cell-surface expression of CEACAM1 by keratinocytes in the context of a psoriatic environment might contribute to the persistence of neutrophils and thus to ongoing inflammation and the decreased propensity for skin infection, typical for patients with psoriasis.

Read more
https://qima-lifesciences.com/wp-content/uploads/2016/05/mw_Cytokine-induced-CEACAM1-expression.jpg 368 655 Guillaume https://qima-lifesciences.com/wp-content/uploads/2021/10/QIMA_life_sciences@4x1.png Guillaume2008-10-09 13:29:202018-10-24 22:06:33Cytokine-induced CEACAM1 expression on keratinocytes is characteristic for psoriatic skin and contributes to a prolonged lifespan of neutrophils
interleukin 22

A role for T cell-derived interleukin 22 in psoriatic skin inflammation

Psoriasis

This study indicate that interleukin 22 is a cytokine produced by skin-infiltrating lymphocytes that is potentially involved in initiation and/or maintenance of the pathogenesis of psoriasis.

Read more
https://qima-lifesciences.com/wp-content/uploads/2007/09/mw_T-cell-derived-interleukin-22.jpg 368 655 Guillaume https://qima-lifesciences.com/wp-content/uploads/2021/10/QIMA_life_sciences@4x1.png Guillaume2007-09-27 16:47:372018-10-24 22:11:29A role for T cell-derived interleukin 22 in psoriatic skin inflammation
OSM

OSM (Oncostatin M) secreted by skin infiltrating T lymphocytes is a potent keratinocyte activator involved in skin inflammation

Psoriasis

These results demonstrate that OSM and its receptor play an important role in cutaneous inflammatory responses in general and that the specific effects of OSM are associated with distinct inflammatory diseases depending on the cytokine environment.

Read more
https://qima-lifesciences.com/wp-content/uploads/2016/05/mw_Oncostatin-M.jpg 368 655 Guillaume https://qima-lifesciences.com/wp-content/uploads/2021/10/QIMA_life_sciences@4x1.png Guillaume2007-04-01 08:56:232018-10-24 22:11:40OSM (Oncostatin M) secreted by skin infiltrating T lymphocytes is a potent keratinocyte activator involved in skin inflammation
IL10

Keratinocytes as targets for IL10-related cytokines : a putative role in psoriasis pathogenesis

Psoriasis

In this review, we discuss recent knowledge about the effects of cytokines of the IL-10 family on keratinocytes and their potential role in psoriasis, a cutaneous inflammatory disease.

Read more
https://qima-lifesciences.com/wp-content/uploads/2016/05/mw_Keratinocytes-as-targets-for-IL-10-related-cytokines.jpg 368 655 Guillaume https://qima-lifesciences.com/wp-content/uploads/2021/10/QIMA_life_sciences@4x1.png Guillaume2005-12-15 09:47:352018-10-24 22:13:04Keratinocytes as targets for IL10-related cytokines : a putative role in psoriasis pathogenesis
IL-22

IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes

Inflammation, Psoriasis

IL-22 belongs to a family of cytokines structurally related to IL-10, including IL-19, IL-20, IL-24, and IL-26. In contrast to IL-10, IL-22 has proinflammatory activities. IL-22 signals through a class II cytokine receptor composed of an IL-22-binding chain, IL-22RA1, and the IL-10RB subunit, which is shared with the IL-10R.

Read more
https://qima-lifesciences.com/wp-content/uploads/2016/05/mw_IL-22-inhibits-epidermal-differentiation.jpg 368 655 Guillaume https://qima-lifesciences.com/wp-content/uploads/2021/10/QIMA_life_sciences@4x1.png Guillaume2005-03-15 11:15:072018-10-24 22:14:26IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes

 

 

NEED MORE INFORMATION?


  • Les informations recueillies sur ce formulaire sont enregistrées dans un fichier informatisé par QIMA LIFE SCIENCES pour vous contacter afin de répondre à votre demande et vous aider à sélectionner le ou les tests les mieux adaptés à votre projet.

  • La base légale du traitement est l’intérêt légitime du QIMA Life Sciences. Les données collectées seront communiquées aux seuls destinataires suivants : Les services concernés et habilités par QIMA Life Sciences. Les données sont conservées pendant une durée de 3 ans à compter de la collecte ou de votre dernier contact entrant.

    Vous pouvez accéder aux données vous concernant, les rectifier, demander leur effacement ou exercer votre droit à la limitation du traitement de vos données, retirer votre consentement au traitement de vos données à tout moment, vous opposer au traitement de vos données et vous disposez d’un droit à la portabilité de vos données.

    Consultez le site cnil.fr pour plus d’informations sur vos droits.

    Pour exercer ces droits vous pouvez nous contacter à l’aide du lien suivant Gestion des droits ou en écrivant à dpo-qima@agencergpd.eu.

    Si vous estimez, après nous avoir contactés, que vos droits « Informatique et Libertés » ne sont pas respectés, vous pouvez adresser une réclamation à la CNIL.

    N.B : Les catégories de données suivantes ; NOM / SOCIETE / EMAIL et PAR QUEL TYPE DE SERVICE ÊTES VOUS INTERESSE sont obligatoires. La non-fourniture de ces informations entrainera l’impossibilité pour QIMA Life Sciences de vous répondre.

  • This field is for validation purposes and should be left unchanged.

Address

QIMA Life Sciences
Headquarters
1bis rue des plantes - CS 50011
86160 Gençay - France
Tel. +33 (0) 5 49 36 11 37
Mail: ls@qima.com

International offices
France - Labège, Lyon
Germany - Münster
USA - Buffalo, NY
Brazil - Botucatu, SP

Latest posts

  • Performance and Tolerance of a Protocol for Idiopathic Chronic Greasy Seborrhea in 18 Dogs Using a Shampoo and Mousse Containing Plant Extracts
  • Evaluation of a new connected portable camera for the analysis of skin microrelief and the assessment of the effect of skin moisturisers
  • Clinical and Microbiological Performances and Effects on Lipid and Cytokine Production of a Ceruminolytic Ear Cleaner in Canine Erythemato-Ceruminous Otitis Externa

Cosmetic

  • Hydration and skin barrier
  • Epidermal regeneration
  • Skin firmness & cohesion
  • Skin ageing
  • Skin protection & defense
  • Skin pigmentation
  • Oily skin and hyperseborrhea
  • Skin microcirculation and vascularization
  • Slimming and adipocyte metabolism
  • Hair growth and alopecia

Pharmacology

  • Immuno-Inflammation
  • Neurobiology
  • Veterinary medicine

Dermatology

  • Acne
  • Hair growth and alopecia
  • Atopic dermatitis
  • Psoriasis
  • Wound healing and skin regeneration
  • Melanoma
  • Vitiligo (coming soon)
© Copyright 2021 - QIMA LTD - Privacy policy - Configuration des Cookies
  • Flickr
  • LinkedIn
  • Youtube
Scroll to top

Forgot password ?

Lost your password? Please enter your email address. You will receive mail with link to set new password.

Retour connexion

Nous utilisons des cookies sur notre site web pour fournir l'expérience utilisateur la plus adaptée possible. Pour cela, nous enregistrons vos préférences au travers de vos différentes visites.
En cliquant sur “Tout accepter”, vous consentez à l'utilisation de l'ensemble des cookies. Si vous le souhaitez, vous pouvez visiter la "Configuration des Cookies" pour contrôler plus précisément votre consentement.
Vous pouvez également consulter notre politique concernant les cookies en cliquant ici.
Tout RejeterConfiguration des CookiesTout Accepter
Manage consent

Privacy Overview

En Français : Ce site web utilise des cookies pour améliorer votre expérience pendant que vous y naviguez. Dans ce contexte, les cookies catégorisés comme nécessaire sont stockés dans votre navigateur afin de permettre le bon comportement des fonctionnalités de base du site web. Nous utilisons également des cookies de tiers qui aident à analyser et à comprendre comment vous utilisez notre site qima-lifesciences.com. Ces cookies vont être stockés sur votre navigateur uniquement avec votre accord préalable. Vous avez la possibilité de refuser d'utiliser tout ou partie de ces cookies mais cela peut fortement détériorer votre expérience de navigation.

In English : This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use the website qima-lifesciences.com. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
CookieDurationDescription
_GA - Google Analytics2 yearsThese cookies set by Google Analytics are used for analytics purposes, including identifying each unique user and details of each page visited. For more information on Google Analytics cookies, see the Google Inc's privacy policy at http://www.google.com/policies/privacy/. You can block the use of Google Analytics cookies by downloading and installing the relevant extra component for your browser from this link: https://tools.google.com/dlpage/gaoptout
_GID - Google Analytics1 dayCe cookie est utilisé par Google Analytics à des fins d'analyses comme par exemple pour identifier chaque utilisateur unique et le détail de chaque page visitée. Pour plus d'information sur les cookies de Google Analytics, vous pouvez consulter la politique de vie privée de Google Inc à l'adresse suivante : http://www.google.com/policies/privacy/. Vous pouvez bloquer l'usage des cookies de Google Analytics en téléchargeant et en installant les composants complémentaires pour votre navigateur internet à l'adresse suivante : https://tools.google.com/dlpage/gaoptout
Advertising
Third-party profiling cookies for marketing and retargeting purposes These cookies are used by QIMA’s partners, upon your prior consent, in order to profile users for advertising and retargeting purposes. They can, for example, create user profiles to serve ads that are in line with your preferences showed as you surf the web; record your choices and activity on our website to carry out statistical analysis – for us or for third parties – by tracking your preferences and browsing behavior, serve customized ads to you, integrate some common feature of the major social media and provide it within the site, etc.
CookieDurationDescription
_gcl_au - Google Analytics4 MonthsThis cookie is used by Google AdSense for experimenting with advertisement efficiency across websites using their services. For more information on Google Analytics cookies, see the Google Inc's privacy policy at http://www.google.com/policies/privacy/. You can block the use of Google Analytics cookies by downloading and installing the relevant extra component for your browser from this link: https://tools.google.com/dlpage/gaoptout
Others
Cookie who haven't been evaluated and classified are displayed here.
Necessary
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-advertising11 MonthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Advertising".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Others".
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
pll_language1 yearused by the site to identify the current user language and display page accordingly.
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
CookieDurationDescription
DV - www.google.com12 MonthsCookie used by Google Maps for saving users settings    
SAVE & ACCEPT

Ressources documentaires


  • Les informations recueillies sur ce formulaire sont enregistrées dans un fichier informatisé par QIMA LIFE SCIENCES pour vous contacter afin de répondre à votre demande et vous aider à sélectionner le ou les tests les mieux adaptés à votre projet.

  • La base légale du traitement est l’intérêt légitime du QIMA Life Sciences. Les données collectées seront communiquées aux seuls destinataires suivants : Les services concernés et habilités par QIMA Life Sciences. Les données sont conservées pendant une durée de 3 ans à compter de la collecte ou de votre dernier contact entrant.

    Vous pouvez accéder aux données vous concernant, les rectifier, demander leur effacement ou exercer votre droit à la limitation du traitement de vos données, retirer votre consentement au traitement de vos données à tout moment, vous opposer au traitement de vos données et vous disposez d’un droit à la portabilité de vos données.

    Consultez le site cnil.fr pour plus d’informations sur vos droits.

    Pour exercer ces droits vous pouvez nous contacter à l’aide du lien suivant Gestion des droits ou en écrivant à dpo-qima@agencergpd.eu.

    Si vous estimez, après nous avoir contactés, que vos droits « Informatique et Libertés » ne sont pas respectés, vous pouvez adresser une réclamation à la CNIL.

    N.B : Les catégories de données suivantes : Email / Pays sont obligatoires. La non-fourniture de ces informations entrainera l’impossibilité pour QIMA Life Sciences de vous répondre.


  • This field is for validation purposes and should be left unchanged.

Documentary Ressources_Flyer_Ceramides


  • Les informations recueillies sur ce formulaire sont enregistrées dans un fichier informatisé par QIMA LIFE SCIENCES pour vous contacter afin de répondre à votre demande et vous aider à sélectionner le ou les tests les mieux adaptés à votre projet.

  • La base légale du traitement est l’intérêt légitime du QIMA Life Sciences. Les données collectées seront communiquées aux seuls destinataires suivants : Les services concernés et habilités par QIMA Life Sciences. Les données sont conservées pendant une durée de 3 ans à compter de la collecte ou de votre dernier contact entrant.

    Vous pouvez accéder aux données vous concernant, les rectifier, demander leur effacement ou exercer votre droit à la limitation du traitement de vos données, retirer votre consentement au traitement de vos données à tout moment, vous opposer au traitement de vos données et vous disposez d’un droit à la portabilité de vos données.

    Consultez le site cnil.fr pour plus d’informations sur vos droits.

    Pour exercer ces droits vous pouvez nous contacter à l’aide du lien suivant Gestion des droits ou en écrivant à dpo-qima@agencergpd.eu.

    Si vous estimez, après nous avoir contactés, que vos droits « Informatique et Libertés » ne sont pas respectés, vous pouvez adresser une réclamation à la CNIL.

    N.B : Les catégories de données suivantes : Email / Pays / Société / Sélectionnez la vidéo sont obligatoires. La non-fourniture de ces informations entrainera l’impossibilité pour QIMA Life Sciences de vous répondre.


  • This field is for validation purposes and should be left unchanged.